emphasis to patient-oriented research. We
are confident that this is the cutting-edge of clinical research. Our hopes
have been amply rewarded by the Center's groundbreaking research into some
of the afflictions that are among the greatest scourges of our society.
It's wonderful to see young, gifted scientists taking up the torch of
pioneering research in the Human Genome era, and we can't wait to see what
the 2008 Winnick Clinical Scholars and larger body of researchers at the
Winnick Family Clinical Research Center will be working on over the coming
year."
The Winnick Family Clinical Research Center is a fully staffed center
for clinical research active in all major clinical departments, utilizing
administration, nursing, and nutritional support, along with core
laboratory services in sample processing, tissue culture, genome screening
and bioinformatics.
'/>"/>SOURCE Winnick Family Clinical Research Center Copyright©2008 PR Newswire. All rights reserved | |
Page: 1 2 Related biology technology :1.
IsoTis Receives FDA Clearance for Accell Family of Products2.
Cardica and Cook Sign Agreement to Expand Cook Vascular Closure Device Product Family3.
Melanoma Research Foundation and Seattle Cancer Care Alliance Host Educational Symposium and Reception for Melanoma Patients, Family Members and Healthcare Providers4.
Chindexs United Family Hospitals and Clinics and NBC Enter into Healthcare Services Agreement5.
Dr. Charles A. Sims of California Cryobanks Family Cord Blood Services Named to National Stem Cell Advisory Council6.
Vaccines are Likely to Cause Insulin Dependent Diabetes in Over 2% of Children With a Strong Family History of Insulin Dependent Diabetes, New Data Indicates7.
Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients8.
EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound9.
Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States10.
The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma11.
PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials